An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference in early access. Small businesses and their workers are often stuck … Read more
Under a proposed revamp of the body-mass-index (BMI) system, millions of Brits could be classified as obese. The World Health Organisation-endorsed system, which measures a person’s weight in relation to their height, is globally used by healthcare professionals to assess an individual’s risk of developing health conditions due to excess body fat. Currently, a healthy … Read more
Diabetes UK warned people have been bombarded by unhealthy food (Image: Getty) Experts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report revealed an alarming surge in type 2 diabetes diagnoses. Almost 168,000 people under the age of 40 are now suffering from the debilitating blood sugar disease … Read more
A new study has found that almost half of all cancer cases are linked to obesity, proving further how crucial it is so stay in shape. The research was carried out by Sweden’s Lund University saw 4.1 million participants who were monitored for about 40 years, with close checks on their weight and lifestyle. Over the … Read more
Experts are warning high levels of fatty liver disease among young people could signal a public health crisis. Fatty liver disease is normally associated with people in their 50’s and 60’s and is linked to excess weight or alcohol use.However a major new study reveals one in five young adults has evidence of fatty liver … Read more
Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after it’s been crushing the S & P 500’s performance over the past three years. The study results released by Eli Lilly on Wednesday highlight the … Read more
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat of GLP-1 weight loss drugs is growing faster than expected. … Read more
There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist Todd Sohn believes hinges on the performance of two … Read more
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The U.S. Food and Drug Administration approved a label change requested by … Read more
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry, rightly, that they’ll regain weight and revert to old habits. In clinical trials, patients who paused the drugs put back on most of the … Read more
